Document is current
Any future updates will be listed below
-
Authors
Kuss, Oliver https://orcid.org/0000-0003-3301-5869
Roden, Michael https://orcid.org/0000-0001-8200-6382
Schlesinger, Sabrina https://orcid.org/0000-0003-4244-0832
Hoyer, Annika https://orcid.org/0000-0002-0241-9951
-
Funding
Funding for this research was provided by:
Universitätsklinikum Düsseldorf. Anstalt öffentlichen Rechts
- License Information
-
More Information
Article History
Received: 27 May 2024
Accepted: 23 November 2024
First Online: 12 December 2024
Declarations
:
: OK received honouraria for biostatistical education from Berlin-Chemie. SS received a speaker honorarium from Novo Nordisk. MR received personal fees from Allergan, Astra-Zeneca, Bristol-Myers-Squibb, Eli Lilly, Fishawack Group, Gilead Sciences, Intercept Pharma, Inventiva, Novartis, Novo Nordisk, Pfizser, Prosciento, Sanofi US and Target RWE and investigator-initiated research support from Boehringer-Ingelheim, Nutricia/Danone and Sanofi-Aventis. AH declares that there are no relationships or activities that might bias, or be perceived to bias, their work.
: This work uses only published and digitalized data that are fully anonymised. We therefore did not seek for ethics approval.
: Not applicable.
